ProShare Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $386K | Sell |
9,519
-269
| -3% | -$10.9K | ﹤0.01% | 1273 |
|
2025
Q1 | $503K | Sell |
9,788
-2,382
| -20% | -$122K | ﹤0.01% | 1095 |
|
2024
Q4 | $674K | Buy |
12,170
+2,970
| +32% | +$164K | ﹤0.01% | 1098 |
|
2024
Q3 | $303K | Buy |
+9,200
| New | +$303K | ﹤0.01% | 1454 |
|
2024
Q2 | – | Sell |
-7,631
| Closed | -$277K | – | 1998 |
|
2024
Q1 | $277K | Buy |
+7,631
| New | +$277K | ﹤0.01% | 1473 |
|